This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luther, H.-P. Articles by Wallukat, G. Search for Related Content PubMed PubMed Citation Articles by Luther, H.-P. Articles by Wallukat, G.

(Hypertension. 1997;29:678-682.)
© 1997 American Heart Association, Inc.

Articles

₁-Adrenergic Receptor Antibodies in Patients With Primary Hypertension

Hans-Peter Luther; Volker Homuth; Gerd Wallukat

the Max Delbruck Center for Molecular Medicine (H.-P.L., G.W.) and the Franz Volhard Clinic (V.H.), Virchow Klinikum, Humboldt University, Berlin, Germany.

Correspondence to Gerd Wallukat, Max Delbruck Center for Molecular Medicine, Robert-Roessle-Str. 10, 13122 Berlin, FRG. E-mail gwalluk@orion.rz.mdc-berlin.de

Autoimmune mechanisms have been proposed to play a role in the pathogenesis of primary (essential) hypertension. Autoantibodies against the ₁-adrenergic receptor have been described in patients with malignant and secondary hypertension. To investigate the incidence of autoantibodies against the ₁-adrenoceptor in patients with primary hypertension, we examined the immunoglobulin fractions of sera from 54 patients with primary hypertension and 26 normotensive control subjects for the presence of autoantibodies against the ₁-adrenoceptor. Sera from 24 patients (44%) and 3 subjects (12%) were positive. An epitope analysis of 16 autoantibody-positive immunoglobulin fractions revealed that in two thirds of the cases, the antibodies were directed against the first extracellular loop of the ₁-adrenoceptor and in one third, against the second. The autoantibodies had a positive chronotropic effect on isolated neonatal rat cardiomyocytes, an effect that was blocked by ₁-adrenergic antagonists. Since the functional characteristics of the autoantibodies showed no desensitization phenomena, they may play a role in elevating peripheral vascular resistance and promoting cardiac hypertrophy in patients with primary hypertension.

Key Words: hypertension, essential • sympathetic nervous system • immune system • receptors, adrenergic, alpha-1 • epitope mapping

This article has been cited by other articles:

				D. C. Kem, X. Yu, E. Patterson, S. Huang, S. Stavrakis, B. Szabo, L. Olansky, J. McCauley, and M. W. Cunningham Autoimmune Hypertensive Syndrome Hypertension, November 1, 2007; 50(5): 829 - 834. [Full Text] [PDF]

				Y. Xia, C. C. Zhou, S. M. Ramin, and R. E. Kellems Angiotensin Receptors, Autoimmunity, and Preeclampsia J. Immunol., September 15, 2007; 179(6): 3391 - 3395. [Abstract] [Full Text] [PDF]

				C. A. Hubel, G. Wallukat, M. Wolf, F. Herse, A. Rajakumar, J. M. Roberts, N. Markovic, R. Thadhani, F. C. Luft, and R. Dechend Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia Hypertension, March 1, 2007; 49(3): 612 - 617. [Abstract] [Full Text] [PDF]

				T. M. Thway, S. G. Shlykov, M.-C. Day, B. M. Sanborn, L. C. Gilstrap III, Y. Xia, and R. E. Kellems Antibodies From Preeclamptic Patients Stimulate Increased Intracellular Ca2+ Mobilization Through Angiotensin Receptor Activation Circulation, September 21, 2004; 110(12): 1612 - 1619. [Abstract] [Full Text] [PDF]

				R. Jahns, V. Boivin, C. Siegmund, F. Boege, M. J. Lohse, and G. Inselmann Activating beta-1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1545 - 1551. [Abstract] [Full Text] [PDF]